Profil
Masayuki Kobayashi is Chairman at Taiho Oncology, Inc. since 2014, President & Representative Director at Taiho Pharmaceutical Co., Ltd. since 2012, and Director at Otsuka Holdings Co., Ltd. since 2017.
Formerly, Mr. Kobayashi was Chief Executive Officer at Otsuka America, Inc.
Aktive Positionen von Masayuki Kobayashi
| Unternehmen | Position | Beginn |
|---|---|---|
| OTSUKA HOLDINGS CO., LTD. | Direktor/Vorstandsmitglied | 30.03.2017 |
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Präsident | 03.04.2012 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Vorsitzender | 01.04.2014 |
Ehemalige bekannte Positionen von Masayuki Kobayashi
| Unternehmen | Position | Ende |
|---|---|---|
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceutical, nutraceutical products & consumer markets | Präsident | 31.03.2012 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Commercial Services |
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceutical, nutraceutical products & consumer markets | Health Technology |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in pharmaceutical preparations | Health Technology |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
















